ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.693,37
0,04%
S&P 500
5.304,72
0,70%
Dow Jones
39.069,59
0,01%
Euro vs US Dollar
1,08485
-0,05%
Bitcoin
69.068,84
0,79%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Cesca Therapeutics Inc (KOOL)

  7. Cesca Therapeutics Inc (KOOL) News

KOOL

Cesca Therapeutics (KOOL)

Cesca Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:KOOL
DatumZeitQuelleÜberschriftSymbolFirma
31/10/201911h30PR Newswire (US)Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic FocusNASDAQ:KOOLCesca Therapeutics Inc
24/10/201914h30PR Newswire (US)Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth ConferenceNASDAQ:KOOLCesca Therapeutics Inc
22/10/201916h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KOOLCesca Therapeutics Inc
22/10/201916h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KOOLCesca Therapeutics Inc
22/10/201912h30PR Newswire (US)Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Serv...NASDAQ:KOOLCesca Therapeutics Inc
14/10/201914h30PR Newswire (US)Cesca Therapeutics To Present At The 2019 Bio Investor ForumNASDAQ:KOOLCesca Therapeutics Inc
02/10/201914h30PR Newswire (US)Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution FeeNASDAQ:KOOLCesca Therapeutics Inc
25/09/201916h25PR Newswire (US)ThermoGenesis Reports Performance Evaluations of X-Series® Cell Processing DevicesNASDAQ:KOOLCesca Therapeutics Inc
24/09/201920h35Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:KOOLCesca Therapeutics Inc
19/09/201900h42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KOOLCesca Therapeutics Inc
19/09/201900h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KOOLCesca Therapeutics Inc
19/09/201900h40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KOOLCesca Therapeutics Inc
12/09/201923h08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:KOOLCesca Therapeutics Inc
11/09/201912h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KOOLCesca Therapeutics Inc
09/09/201914h30PR Newswire (US)Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® ProductsNASDAQ:KOOLCesca Therapeutics Inc
06/09/201923h26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KOOLCesca Therapeutics Inc
03/09/201914h30PR Newswire (US)Cesca Therapeutics To Present At The H.C. Wainwright 21st Annual Global Investment ConferenceNASDAQ:KOOLCesca Therapeutics Inc
14/08/201912h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KOOLCesca Therapeutics Inc
13/08/201922h35Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KOOLCesca Therapeutics Inc
13/08/201922h05PR Newswire (US)Cesca Therapeutics Announces Improved Second Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:KOOLCesca Therapeutics Inc
06/08/201914h30PR Newswire (US)Cesca Therapeutics To Announce Financial Results For The Second Quarter Ended June 30, 2019 And Host A Conference Call On Aug...NASDAQ:KOOLCesca Therapeutics Inc
29/07/201923h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KOOLCesca Therapeutics Inc
29/07/201918h47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KOOLCesca Therapeutics Inc
23/07/201914h30PR Newswire (US)America's Largest Cord Blood Bank, CBR®, Upgrading to ThermoGenesis' AXP® II SystemNASDAQ:KOOLCesca Therapeutics Inc
11/07/201922h35Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:KOOLCesca Therapeutics Inc
26/06/201920h52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KOOLCesca Therapeutics Inc
26/06/201914h30PR Newswire (US)Cesca Therapeutics Regains Nasdaq Listing ComplianceNASDAQ:KOOLCesca Therapeutics Inc
25/06/201914h30PR Newswire (US)Cordlife to Use the ThermoGenesis AXP® II System for Rapid Processing of Cord Blood Units in IndiaNASDAQ:KOOLCesca Therapeutics Inc
18/06/201914h30PR Newswire (US)ThermoGenesis Receives Health Canada Approval of its Next-Generation AXP® II System for Cord Blood ProcessingNASDAQ:KOOLCesca Therapeutics Inc
05/06/201914h30PR Newswire (US)ThermoGenesis to Participate in The Orthobiologic Institute's 10th Annual PRP & Regenerative Medicine SymposiumNASDAQ:KOOLCesca Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:KOOL

Kürzlich von Ihnen besucht

COIN
IBTCETH
iBTC
ASX
HVN
Harvey Norman
COIN
MPGGETH
MedPing
AMEX
FLMI
Franklin Dynamic Municip...
NASDAQ
VMIXX
Jpmorgan Prime MM Fund Agency Sh
USOTC
LNDES
Landa App (GM)
USOTC
CSAY
China SheSays Medical Co... (GM)
NASDAQ
ABBMYXX
Citigroup Global Markets...
NYSE
BMRG.WS
B Riley Principal Merger...
GDAX
GFIUSD
Goldfinch
GDAX
INDEXUSDT
Index
ASX
CCLSOG
LSE
0J45
Vrancart
BIT
NSCIT5562722
Anubi Spe Srl
BIT
BUND5S
Solactive leveraged shor...
BIT
UB4Q7R
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten